Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome : a randomised, double- blind, placebo controlled, multi-centre, pilot clinical study
Muhammed Majeed Artikkel Engelsk
Logg inn for flere valg
*0011280292 *008181114s2018 xx# 000 0 eng *019 $bk *08230$a616.85270654 *100 $aMajeed, Muhammed$4aut$_150130300 *245 $aBacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome$ba randomised, double- blind, placebo controlled, multi-centre, pilot clinical study *300 $a15 s. : ill. *500 $aVitenskapelig artikkel *5208 $aInneholder sammendrag *650 $aDepresjon$2norart$_12395700 *650 $airritabel tarm (IBS)$9nor$2norart$_130088300 *650 $aprobiotika$9nor$2norart$_133479100 *653 $aB. coagulans MTCC 5856$9eng$_150130400 *653 $aLactoSpore®$9eng$_150130500 *653 $airritable bowel syndrome$9eng$_150130600 *653 $amajor depression$9eng$_131464600 *653 $aprobiotic$9eng$_150130700 *700 $aAli, Furqan$4aut$_150130800 *700 $aArumugam, Sivakumar;$4aut$_150130900 *700 $aMajeed, Shaheen;$4aut$_150131000 *700 $aNagabhushanam, Kalyanam;$4aut$_150131100 *773 $tFood & nutrition research (online) (elektronisk ressurs)$gVol. 62 (2018)$x1654-661X *8564 $uhttps://doi.org/10.29219/fnr.v62.1218 *999 $z1800634698$anorart:1800634698 ^